Pivotal-Safety and Therapeutic Measures of tDCS in Patients With Refractory Focal Epilepsy
Public ClinicalTrials.gov record NCT04770337. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
STARSTIM: SAFETY AND THERAPEUTIC MEASURES OF TRANSCRANIAL CATHODAL DIRECT CURRENT STIMULATION (TDCS) IN PATIENTS WITH REFRACTORY FOCAL EPILEPSY
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a multiple site, randomized, double blinded parallel-group controlled study. The purpose of this study is to evaluate efficacy, safety, and tolerability of repeated, daily sessions with the STARSTIM device, which delivers transcranial cathodal direct current stimulation (tDCS). Subjects will be treated with STARTSTIM or sham device for 10 sessions over a 2-week period. The subjects will be followed for an additional 10 weeks post treatment. Quality of Life questionnaires and adverse events will be collected and evaluated.
Study identification
- NCT ID
- NCT04770337
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 127 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 9 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 25, 2021 (Actual)
- Primary completion
- Jan 12, 2026 (Actual)
- Completion
- Jan 12, 2026 (Actual)
- Last update posted
- Apr 8, 2026
2021 – 2026
United States locations
- U.S. sites
- 18
- U.S. states
- 14
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Barrow Neurological Institute, St. Joseph's Hospital & Medical Center | Phoenix | Arizona | 85013 | — |
| Loma Linda University Health | Loma Linda | California | 92354 | — |
| Keck Medicine of USC | Los Angeles | California | 90033 | — |
| Children's Hospital of Orange County | Orange | California | 92868 | — |
| University of Florida Jacksonville | Jacksonville | Florida | 32209 | — |
| Southern Illinois University School of Medicine | Springfield | Illinois | 62702 | — |
| Sinai Hospital | Baltimore | Maryland | 21215 | — |
| Johns Hopkins University | Baltimore | Maryland | 21287 | — |
| Boston Children's Hospital Comprehensive Epilepsy Center | Boston | Massachusetts | 02115 | — |
| Beth Israel Deconess Medical Center | Boston | Massachusetts | 02215 | — |
| Mayo Clinic | Rochester | Minnesota | 55905 | — |
| Washington University Medical Center | St Louis | Missouri | 63110 | — |
| Robert Wood Johnson Medical School (Rutgers) | New Brunswick | New Jersey | 08901 | — |
| University of Rochester | Rochester | New York | 14642 | — |
| University of Pennsylvania (Penn Epilepsy) | Philadelphia | Pennsylvania | 19104 | — |
| Vanderbilt University Medical Center | Nashville | Tennessee | 37212 | — |
| University Of Utah | Salt Lake City | Utah | 84132 | — |
| Seattle Children's Hospital, University of Washington | Seattle | Washington | 98105 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 14 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04770337, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 8, 2026 · Synced Oct 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT04770337 live on ClinicalTrials.gov.